Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder
- PMID: 24344788
- DOI: 10.1111/jsm.12363
Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder
Abstract
Introduction: At the start of gender reassignment therapy, persons with a gender identity disorder (GID) may deal with various forms of psychopathology. Until now, a limited number of publications focus on the effect of the different phases of treatment on this comorbidity and other psychosocial factors.
Aims: The aim of this study was to investigate how gender reassignment therapy affects psychopathology and other psychosocial factors.
Methods: This is a prospective study that assessed 57 individuals with GID by using the Symptom Checklist-90 (SCL-90) at three different points of time: at presentation, after the start of hormonal treatment, and after sex reassignment surgery (SRS). Questionnaires on psychosocial variables were used to evaluate the evolution between the presentation and the postoperative period. The data were statistically analyzed by using SPSS 19.0, with significance levels set at P < 0.05.
Main outcome measures: The psychopathological parameters include overall psychoneurotic distress, anxiety, agoraphobia, depression, somatization, paranoid ideation/psychoticism, interpersonal sensitivity, hostility, and sleeping problems. The psychosocial parameters consist of relationship, living situation, employment, sexual contacts, social contacts, substance abuse, and suicide attempt.
Results: A difference in SCL-90 overall psychoneurotic distress was observed at the different points of assessments (P = 0.003), with the most prominent decrease occurring after the initiation of hormone therapy (P < 0.001). Significant decreases were found in the subscales such as anxiety, depression, interpersonal sensitivity, and hostility. Furthermore, the SCL-90 scores resembled those of a general population after hormone therapy was initiated. Analysis of the psychosocial variables showed no significant differences between pre- and postoperative assessments.
Conclusions: A marked reduction in psychopathology occurs during the process of sex reassignment therapy, especially after the initiation of hormone therapy.
Keywords: Gender Dysphoria; Gender Identity Disorder; Gender Reassignment Therapy; Psychopathology.
© 2013 International Society for Sexual Medicine.
Similar articles
-
Gender identity disorder and eating disorders: similarities and differences in terms of body uneasiness.J Sex Med. 2013 Apr;10(4):1012-23. doi: 10.1111/jsm.12062. Epub 2013 Jan 24. J Sex Med. 2013. PMID: 23347389
-
Sexual quality of life in gender-dysphoric adults before genital sex reassignment surgery.J Sex Med. 2015 Jan;12(1):180-8. doi: 10.1111/jsm.12758. Epub 2014 Nov 17. J Sex Med. 2015. PMID: 25401972
-
[Gender dysphoria in children and adolescents - treatment guidelines and follow-up study].Z Kinder Jugendpsychiatr Psychother. 2015 Jan;43(1):47-55. doi: 10.1024/1422-4917/a000332. Z Kinder Jugendpsychiatr Psychother. 2015. PMID: 25536896 German.
-
Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.Pharmacotherapy. 2014 Dec;34(12):1282-97. doi: 10.1002/phar.1487. Epub 2014 Sep 15. Pharmacotherapy. 2014. PMID: 25220381 Review.
-
Gender dysphoria and children.J Psychosoc Nurs Ment Health Serv. 2014 Aug;52(8):27-30. doi: 10.3928/02793695-20140625-01. Epub 2014 Jun 25. J Psychosoc Nurs Ment Health Serv. 2014. PMID: 24972388 Review.
Cited by 33 articles
-
Current use of testosterone therapy in LGBTQ populations.Int J Impot Res. 2021 Nov 23. doi: 10.1038/s41443-021-00490-z. Online ahead of print. Int J Impot Res. 2021. PMID: 34815551 Review.
-
Return to work of transgender people: A systematic review through the blender of occupational health.PLoS One. 2021 Nov 1;16(11):e0259206. doi: 10.1371/journal.pone.0259206. eCollection 2021. PLoS One. 2021. PMID: 34723993 Free PMC article.
-
SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people.J Endocrinol Invest. 2021 Oct 22. doi: 10.1007/s40618-021-01694-2. Online ahead of print. J Endocrinol Invest. 2021. PMID: 34677807
-
Centralized and Decentralized Delivery of Transgender Health Care Services: A Systematic Review and a Global Expert Survey in 39 Countries.Front Endocrinol (Lausanne). 2021 Sep 24;12:717914. doi: 10.3389/fendo.2021.717914. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34630327 Free PMC article.
-
Body Mass Index Requirements for Gender-Affirming Surgeries Are Not Empirically Based.Transgend Health. 2021 Jun 2;6(3):121-124. doi: 10.1089/trgh.2020.0068. eCollection 2021 Jun. Transgend Health. 2021. PMID: 34414267
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
